The Guardian asks how people are supposed to talk about bodies in the Ozempic era

The Guardian published a feature on August 25, 2026 asking how people should discuss bodies now that visible weight change is common and often tied to drugs like Ozempic (semaglutide). The piece put the question to eating disorder clinicians and advocacy leaders, and the advice that came back was mostly to step out of body commentary altogether — including remarks meant as praise ^[1].

What the experts told the Guardian

Dr. Tom Hildebrandt, director of the Center for Eating and Weight Disorders at Mount Sinai hospital in New York, described the current moment as a "whiplash moment we're stuck in." He said the body positivity push of the 2010s, which encouraged people to "accept all body sizes, shapes and types," "took a hard right turn" with the explosion of GLP-1s, and that "the media went through its idealization of weight loss" again ^[1].

Dr. Ulrike Schmidt, professor of eating disorders at King's College London, said the vocabulary has shifted toward "optimizing" one's body and appearance ^[1]. She cautioned that "even the seemingly most innocent and well-meaning comments about people's body weight, shape or appearance have the potential for backfiring, sensitizing or hurting people." In her clinical work, she said, many patients trace the start of their eating disorder to a comment about their body — sometimes a criticism, sometimes a compliment. "In clinic, we often hear that these kinds of congratulatory comments … made them think they are only acceptable, attractive and desirable if they are a certain weight or physique," Schmidt said ^[1].

Schmidt pointed to a 2023 report from the Butterfly Foundation, Australia's national charity for eating disorders and body image, which found 57% of young people were dissatisfied with how they look and 49% said this had sometimes kept them from attending school ^[1].

Jessica Scheer, CEO of the National Eating Disorders Association, framed social media as the main amplifier: "The internet, specifically social media, has made commentary on the appearance of others more visible and widespread," she said. "Most of the commentary is speculative, and almost all of it is harmful" ^[1]. On whether posting about someone else's body is ever useful, Hildebrandt said, "I haven't heard of one yet" ^[1].

The experts did draw a line between public speculation and private concern. Hildebrandt said context matters — a conversation "means something different in your physician's office than it does on a social media account for the whole world to see" ^[1]. For worries about a friend or family member, he advised, "Be inquisitive, honest and open. Don't jump to a solution." Scheer suggested centering a conversation not on appearance but on "the other aspects that generally accompany an eating disorder, like social isolation and brain fog" ^[1].

Why it matters for patients

People taking semaglutide or tirzepatide often experience visible change, and the Guardian piece is a reminder that bystanders cannot tell from looking whether a change is intended, medically driven, a side effect, or a warning sign ^[1]. The clinicians quoted treat that uncertainty as a reason to say nothing about anyone's body rather than to guess ^[1].

That has two practical implications. First, patients may field comments — including compliments — that assume a story the speaker does not know. Hildebrandt's suggestion for handling ambient body talk was to "be bored by it" and change the subject, noting that most such remarks are "more like a reflex" than an insult ^[1]. Second, for people with a history of disordered eating, the experts describe appearance-focused praise as a possible trigger, not a neutral kindness ^[1]. NEDA's own tips, cited in the piece, include limiting screen time and asking of media messages: "Who created and profits from the message?" ^[1]

The feature is a normative discussion, not clinical research. It does not report how many people's weight change is now drug-related, does not cite any GLP-1 trial data, and does not address eating disorder risk or screening among people taking these medications. Those questions are not answered in this source.

What happens next

The Guardian published the piece on August 25, 2026, and framed it against recent coverage of celebrity body debates, including an August 8, 2026 interactive on Ariana Grande ^[1]. No policy step, guideline or study is attached to the article, so there is no scheduled follow-up to track from this source.